Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Patrick Morrison

doi:10.1016/S0140-6736(11)61049-0

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Patrick Morrison

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

869 Citations (Scopus)

Original language	English
Pages (from-to)	2081-2087
Number of pages	7
Journal	Lancet
Volume	378
Issue number	9809
DOIs	https://doi.org/10.1016/S0140-6736(11)61049-0
Publication status	Published - 17 Dec 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(11)61049-0

Cite this

@article{6f06b1e14c0541e78a8bf67d31681214,

title = "Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.",

author = "Patrick Morrison",

year = "2011",

month = dec,

day = "17",

doi = "10.1016/S0140-6736(11)61049-0",

language = "English",

volume = "378",

pages = "2081--2087",

journal = "Lancet",

publisher = "Elsevier B.V.",

number = "9809",

}

TY - JOUR

T1 - Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

AU - Morrison, Patrick

PY - 2011/12/17

Y1 - 2011/12/17

U2 - 10.1016/S0140-6736(11)61049-0

DO - 10.1016/S0140-6736(11)61049-0

M3 - Article

C2 - 22036019

VL - 378

SP - 2081

EP - 2087

JO - Lancet

JF - Lancet

IS - 9809

ER -